Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ventricular Tachycardia (VT) Ablation or Escalated Drug Therapy (VANISH)

This study has been completed.
Sponsor:
Collaborators:
St. Jude Medical
Biosense Webster, Inc.
Canadian Institutes of Health Research (CIHR)
Information provided by (Responsible Party):
John Sapp, Nova Scotia Health Authority
ClinicalTrials.gov Identifier:
NCT00905853
First received: May 20, 2009
Last updated: July 8, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2015
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):